Discover Our New CTMS
Tuesday, July 21, 2020 | 10:30 AM–11:30 AM EDT |
Part 4: Clinical Trials and COVID-19 Remote Investigator Meetings
Complete the form to view the recording.
The novel COVID-19 virus has forced a lot of rapid changes in a very short period. Personally and professionally, we are all learning how to adapt. While restrictions on our day-to-day lives impact where, why, and how we interact, we still can come together as a community to learn, grow, and overcome.
TransPerfect's Trial Interactive presents Part 4 of the Clinical Trials and COVID-19 webinar series with industry-expert Penelope K. Manansco to discuss the best strategy for remote investigator meetings.
Your Site Initiation Visit (SIV) is a perfect opportunity to explore remote capabilities. As we are forced to have contingency plans for uncertain times, having the ability to run remote SIVs will help ensure the progress of a study, while also lending advantages to cost, time, oversight, and efficiency. Part 4 of our webinar series will discuss the following, among other topics:
Our two panelists have collectively spent over two decades leading the industry toward remote processes and developing the methods and solutions to make it possible.
Questions? Email firstname.lastname@example.org
Penelope Manasco, M.D.
CEO, MANA RBM